Last reviewed · How we verify

Nicoderm Patch

US Department of Veterans Affairs · FDA-approved active Small molecule

Nicotine binds to nicotinic acetylcholine receptors in the brain, providing nicotine replacement to reduce cravings and withdrawal symptoms during smoking cessation.

Nicotine binds to nicotinic acetylcholine receptors in the brain, providing nicotine replacement to reduce cravings and withdrawal symptoms during smoking cessation. Used for Smoking cessation aid.

At a glance

Generic nameNicoderm Patch
Also known asNicoderm 21mg, NPN: #02093146, Nicoderm 14mg, NPN: #02093138, Nicoderm 7mg, NPN: #02093111, NRT patch, nicotine patch
SponsorUS Department of Veterans Affairs
Drug classNicotine replacement therapy (NRT)
TargetNicotinic acetylcholine receptors
ModalitySmall molecule
Therapeutic areaAddiction Medicine / Smoking Cessation
PhaseFDA-approved

Mechanism of action

Nicoderm is a transdermal patch that delivers nicotine across the skin into the bloodstream. By activating nicotinic acetylcholine receptors, it mimics the effects of smoking without the harmful combustion byproducts, thereby reducing the urge to smoke and alleviating withdrawal symptoms such as irritability, anxiety, and difficulty concentrating.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results